Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [31] The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge
    Bernhard Straubhaar
    Stephan Krähenbühl
    Raymond G. Schlienger
    Drug Safety, 2006, 29 : 79 - 90
  • [32] Evaluation of Potential Drug-Drug Interactions in Hypercholesterolemia Patients at Teaching Hospital Surabaya
    Faizah, Ana Khusnul
    Nurrahman, Nani Wijayanti Dyah
    PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON SUSTAINABLE INNOVATION 2020 - HEALTH SCIENCE AND NURSING (ICOSIHSN 2020), 2021, 33 : 302 - 304
  • [33] DRUG-DRUG INTERACTIONS IN HOSPITAL
    MOK, H
    MULPETER, K
    OCONNOR, P
    FEELY, J
    IRISH MEDICAL JOURNAL, 1991, 84 (01) : 26 - 26
  • [34] POTENTIAL DRUG-DRUG INTERACTIONS IN PSYCHIATRIC PATIENTS DURING HOSPITALIZATION AND AT HOSPITAL DISCHARGE
    Todorova-Nenova, Koraliya
    Zhelyazkova-Savova, Maria
    Gancheva, Silvia
    Stoychev, Elitsa
    JOURNAL OF IMAB, 2022, 28 (01): : 4223 - 4228
  • [35] The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge
    Straubhaar, B
    Krähenbühl, S
    Schlienger, RG
    DRUG SAFETY, 2006, 29 (01) : 79 - 90
  • [36] Trends and Determinants of Polypharmacy and Potential Drug-Drug Interactions at Discharge From Hospital Between 2009-2015
    Abolhassani, Nazanin
    Castioni, Julien
    Santschi, Valerie
    Waeber, Gerard
    Marques-Vidal, Pedro
    JOURNAL OF PATIENT SAFETY, 2021, 17 (08) : E1171 - E1178
  • [37] High frequency of polypharmacy and drug-drug interactions in an elderly HIV population on antiretroviral therapy
    Bourneau-Martin, D.
    Ruellan, A.
    Joyau, C.
    Secher, S.
    Allavena, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [38] Drug-Drug Interactions among Elderly Patients with Diabetes
    Misra, Arpit
    Hansen, Leigh G.
    Chang, Stella
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S242 - S243
  • [39] Drug-drug interactions in a cohort of hospitalized elderly patients
    Pasina, Luca
    Djade, Codjo D.
    Nobili, Alessandro
    Tettamanti, Mauro
    Franchi, Carlotta
    Salerno, Francesco
    Corrao, Salvatore
    Marengoni, Alessandra
    Iorio, Alfonso
    Marcucci, Maura
    Mannucci, Pier Mannuccio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (10) : 1054 - 1060
  • [40] Polypharmacy and the risk of drug-drug interactions among Danish elderly - A prescription database study
    Rosholm, JU
    Bjerrum, L
    Hallas, J
    Worm, J
    Gram, LF
    DANISH MEDICAL BULLETIN, 1998, 45 (02): : 210 - 213